Blood Filtration and Purification Market Size, Share, and Trends 2026 to 2035

Payal Rabde is a healthcare market research analyst. She researched the market trends in blood filtration and purification technologies, therapeutic uses, product adoption, and regulatory and clinical advances. As a researcher, she helps medical device companies, healthcare systems, blood processing companies, and investors benchmark and develop decision-making strategies. The blood filtration and purification market reached 3.97 billion in 2025.

Last Updated : 04 Sep 2026  |  Report Code : 8703  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Blood Filtration and Purification Market 

5.1. COVID-19 Landscape: Blood Filtration and Purification Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Blood Filtration and Purification Market, By Product

8.1. Blood Filtration and Purification Market Revenue and Volume, by Product

8.1.1 Filtration Kits & Reagents

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Membranes, Filters & Consumables

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Sample Preparation Systems

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Specialty Assays & Columns

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Blood Filtration and Purification Market, By Application

9.1. Blood Filtration and Purification Market Revenue and Volume, by Application

9.1.1. Infectious Disease Diagnostics

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Toxicology & Immunodiagnostics

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Cancer Diagnostics

9.1.3.1. Market Revenue and Volume Forecast

9.1.4. Genetic & Molecular Diagnostics

9.1.4.1. Market Revenue and Volume Forecast

9.1.5. Therapeutic Blood Purification

9.1.5.1. Market Revenue and Volume Forecast

9.1.6. Other Applications

9.1.6.1. Market Revenue and Volume Forecast

Chapter 10. Global Blood Filtration and Purification Market, By End User

10.1. Blood Filtration and Purification Market Revenue and Volume, by End User

10.1.1. Clinical Diagnostic Laboratories

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Hospitals

10.1.2.1. Market Revenue and Volume Forecast

10.1.3. Research & Academic Institutes

10.1.3.1. Market Revenue and Volume Forecast

10.1.4. Blood Banks & Transfusion Centers

10.1.4.1. Market Revenue and Volume Forecast

10.1.5. Other End Users

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Blood Filtration and Purification Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Volume Forecast, by Product

11.1.2. Market Revenue and Volume Forecast, by Application

11.1.3. Market Revenue and Volume Forecast, by End User

11.1.4. U.S.

11.1.4.1. Market Revenue and Volume Forecast, by Product

11.1.4.2. Market Revenue and Volume Forecast, by Application

11.1.4.3. Market Revenue and Volume Forecast, by End User

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Volume Forecast, by Product

11.1.5.2. Market Revenue and Volume Forecast, by Application

11.1.5.3. Market Revenue and Volume Forecast, by End User

11.2. Europe

11.2.1. Market Revenue and Volume Forecast, by Product

11.2.2. Market Revenue and Volume Forecast, by Application

11.2.3. Market Revenue and Volume Forecast, by End User

11.2.4. UK

11.2.4.1. Market Revenue and Volume Forecast, by Product

11.2.4.2. Market Revenue and Volume Forecast, by Application

11.2.4.3. Market Revenue and Volume Forecast, by End User

11.2.5. Germany

11.2.5.1. Market Revenue and Volume Forecast, by Product

11.2.5.2. Market Revenue and Volume Forecast, by Application

11.2.5.3. Market Revenue and Volume Forecast, by End User

11.2.6. France

11.2.6.1. Market Revenue and Volume Forecast, by Product

11.2.6.2. Market Revenue and Volume Forecast, by Application

11.2.6.3. Market Revenue and Volume Forecast, by End User

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Volume Forecast, by Product

11.2.7.2. Market Revenue and Volume Forecast, by Application

11.2.7.3. Market Revenue and Volume Forecast, by End User

11.3. APAC

11.3.1. Market Revenue and Volume Forecast, by Product

11.3.2. Market Revenue and Volume Forecast, by Application

11.3.3. Market Revenue and Volume Forecast, by End User

11.3.4. India

11.3.4.1. Market Revenue and Volume Forecast, by Product

11.3.4.2. Market Revenue and Volume Forecast, by Application

11.3.4.3. Market Revenue and Volume Forecast, by End User

11.3.5. China

11.3.5.1. Market Revenue and Volume Forecast, by Product

11.3.5.2. Market Revenue and Volume Forecast, by Application

11.3.5.3. Market Revenue and Volume Forecast, by End User

11.3.6. Japan

11.3.6.1. Market Revenue and Volume Forecast, by Product

11.3.6.2. Market Revenue and Volume Forecast, by Application

11.3.6.3. Market Revenue and Volume Forecast, by End User

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Volume Forecast, by Product

11.3.7.2. Market Revenue and Volume Forecast, by Application

11.3.7.3. Market Revenue and Volume Forecast, by End User

11.4. MEA

11.4.1. Market Revenue and Volume Forecast, by Product

11.4.2. Market Revenue and Volume Forecast, by Application

11.4.3. Market Revenue and Volume Forecast, by End User

11.4.4. GCC

11.4.4.1. Market Revenue and Volume Forecast, by Product

11.4.4.2. Market Revenue and Volume Forecast, by Application

11.4.4.3. Market Revenue and Volume Forecast, by End User

11.4.5. North Africa

11.4.5.1. Market Revenue and Volume Forecast, by Product

11.4.5.2. Market Revenue and Volume Forecast, by Application

11.4.5.3. Market Revenue and Volume Forecast, by End User

11.4.6. South Africa

11.4.6.1. Market Revenue and Volume Forecast, by Product

11.4.6.2. Market Revenue and Volume Forecast, by Application

11.4.6.3. Market Revenue and Volume Forecast, by End User

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Volume Forecast, by Product

11.4.7.2. Market Revenue and Volume Forecast, by Application

11.4.7.3. Market Revenue and Volume Forecast, by End User

11.5. Latin America

11.5.1. Market Revenue and Volume Forecast, by Product

11.5.2. Market Revenue and Volume Forecast, by Application

11.5.3. Market Revenue and Volume Forecast, by End User

11.5.4. Brazil

11.5.4.1. Market Revenue and Volume Forecast, by Product

11.5.4.2. Market Revenue and Volume Forecast, by Application

11.5.4.3. Market Revenue and Volume Forecast, by End User

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Volume Forecast, by Product

11.5.5.2. Market Revenue and Volume Forecast, by Application

11.5.5.3. Market Revenue and Volume Forecast, by End User

Chapter 12. Company Profiles

12.1. Fresenius Medical Care

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. DaVita

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. Baxter

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. B. Braun

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Nipro

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Asahi Kasei

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Abbott

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Abbott

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Abbott

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. Abbott

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : Blood filtration and purification refer to medical technologies for the removal of unwanted substances or toxins from blood. The technologies used may involve filtration, adsorption, and hemoperfusion.

Answer : They are particularly used in patients with kidney failure, critical care, septic illness, poisoning, autoimmune diseases, and other conditions when the elimination of one or more substances from the bloodstream helps the clinical care of a patient. The applications will vary depending on the technology and the approved or established clinical use for the technology.

Answer : Technology components that are important are membrane filtration, hemofiltration, hemodiafiltration, hemoperfusion, adsorption, and selective plasma or blood component separation. Current developments in technology will increasingly be directed to improve selectivity, effectiveness, biocompatibility, and treatment safety.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client